| NO |
Title |
Date |
Submission Obligator |
| 10 |
30% or More Changes in Sales or Profits/Losses (15% or More in the case of Large-scale Corporations) |
2021/01/19 |
HANALL BIOPHARMA CO.,LTD |
| 9 |
Interim Report on Business Performance(Fair Disclosure) |
2021/01/19 |
HANALL BIOPHARMA CO.,LTD |
| 8 |
[Revised]Organization of Investor Relations Event |
2020/12/21 |
HANALL BIOPHARMA CO.,LTD |
| 7 |
Closure of Stock Transfer (Shareholder's Registry) |
2020/12/16 |
HANALL BIOPHARMA CO.,LTD |
| 6 |
[Revised]Organization of Investor Relations Event |
2020/11/03 |
HANALL BIOPHARMA CO.,LTD |
| 5 |
Interim Report on Business Performance(Fair Disclosure) |
2020/10/29 |
HANALL BIOPHARMA CO.,LTD |
| 4 |
[Revised]Organization of Investor Relations Event |
2020/10/23 |
HANALL BIOPHARMA CO.,LTD |
| 3 |
Organization of Investor Relations Event |
2020/10/19 |
HANALL BIOPHARMA CO.,LTD |
| 2 |
[Revised]Organization of Investor Relations Event |
2020/08/18 |
HANALL BIOPHARMA CO.,LTD |
| 1 |
Organization of Investor Relations Event |
2020/08/14 |
HANALL BIOPHARMA CO.,LTD |